Cargando…

Psoriatic arthritis is associated with adverse body composition predictive of greater coronary heart disease and type 2 diabetes propensity – a cross-sectional study

OBJECTIVES: To compare body composition in PsA with metabolic disease free (MDF) controls and type 2 diabetes and assess body-composition predicted propensity for cardiometabolic disease. METHODS: Detailed MRI body composition profiles of 26 PsA participants from the IMAPA study were compared with 1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ferguson, Lyn D, Linge, Jennifer, Dahlqvist Leinhard, Olof, Woodward, Rosemary, Hall Barrientos, Pauline, Roditi, Giles, Radjenovic, Aleksandra, McInnes, Iain B, Siebert, Stefan, Sattar, Naveed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024001/ https://www.ncbi.nlm.nih.gov/pubmed/33147607 http://dx.doi.org/10.1093/rheumatology/keaa604

Ejemplares similares

Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease—results of the Immune Metabolic Associations in Psoriatic Arthritis study
por: Ferguson, Lyn D, et al.
Publicado: (2021)

Association of central adiposity with psoriasis, psoriatic arthritis and rheumatoid arthritis: a cross-sectional study of the UK Biobank
por: Ferguson, Lyn D, et al.
Publicado: (2019)

Reply to: "Rationale of adding muscle volume to muscle fat infiltration in the definition of an adverse muscle composition is unclear"
por: Linge, Jennifer, et al.
Publicado: (2021)

Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLD
por: Linge, Jennifer, et al.
Publicado: (2020)

On the Definition of Sarcopenia in the Presence of Aging and Obesity—Initial Results from UK Biobank
por: Linge, Jennifer, et al.
Publicado: (2020)

Sub‐phenotyping Metabolic Disorders Using Body Composition: An Individualized, Nonparametric Approach Utilizing Large Data Sets
por: Linge, Jennifer, et al.
Publicado: (2019)

Cutaneous lesions in psoriatic arthritis are enriched in chemokine transcriptomic pathways
por: Johnsson, Hanna, et al.
Publicado: (2023)

Synovial Tissue Response to Treatment in Psoriatic Arthritis
por: Codullo, Veronica, et al.
Publicado: (2011)

Adverse muscle composition is a significant risk factor for all-cause mortality in NAFLD
por: Linge, Jennifer, et al.
Publicado: (2022)

Adverse muscle composition predicts all‐cause mortality in the UK Biobank imaging study
por: Linge, Jennifer, et al.
Publicado: (2021)

Erratum to: Secukinumab: A New Treatment Option for Psoriatic Arthritis
por: Mease, Philip, et al.
Publicado: (2016)

Cardiovascular magnetic resonance for the detection of descending thoracic aorta calcification in patients with end-stage renal disease
por: Edy, Elbert, et al.
Publicado: (2021)

Comparing the interobserver reproducibility of different regions of interest on multi-parametric renal magnetic resonance imaging in healthy volunteers, patients with heart failure and renal transplant recipients
por: Rankin, Alastair J., et al.
Publicado: (2019)

Do the pleiotropic effects of statins in the vasculature predict a role in inflammatory diseases?
por: McCarey, David W, et al.
Publicado: (2005)

Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis
por: Welsh, Paul, et al.
Publicado: (2016)

Association of Cardiac Biomarkers With Cardiovascular Outcomes in Patients With Psoriatic Arthritis and Psoriasis: A Longitudinal Cohort Study
por: Colaco, Keith, et al.
Publicado: (2022)

Characteristics of rheumatoid arthritis and its association with major comorbid conditions: cross-sectional study of 502 649 UK Biobank participants
por: Siebert, Stefan, et al.
Publicado: (2016)

Macrophage dysfunction in Psoriatic Arthritis
por: Wenink, Mark H, et al.
Publicado: (2011)

Metatarsophalangeal joint pain in psoriatic arthritis: a cross-sectional study
por: Turner, Deborah E., et al.
Publicado: (2014)

Brodalumab in psoriatic arthritis: results from the randomised phase III AMVISION-1 and AMVISION-2 trials
por: Mease, Philip J, et al.
Publicado: (2021)

The role of IL-17A in axial spondyloarthritis and psoriatic arthritis: recent advances and controversies
por: McGonagle, Dennis G, et al.
Publicado: (2019)

JAK inhibitors and infections risk: focus on herpes zoster
por: Sunzini, Flavia, et al.
Publicado: (2020)

Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data
por: Iliodromiti, Stamatina, et al.
Publicado: (2022)

Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials
por: Sweet, Kristen, et al.
Publicado: (2021)

The characterisation and regulation of type 1 immune responses in psoriatic arthritis
por: Gracie, JA, et al.
Publicado: (2002)

Why did IL-23p19 inhibition fail in AS: a tale of tissues, trials or translation?
por: Siebert, Stefan, et al.
Publicado: (2019)

JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
por: Fragoulis, George E, et al.
Publicado: (2019)

Comparison of lipid and lipid-associated cardiovascular risk marker changes after treatment with tocilizumab or adalimumab in patients with rheumatoid arthritis
por: Gabay, Cem, et al.
Publicado: (2016)

Cardiovascular risk factors and body composition in adults with achondroplasia
por: Fredwall, Svein O., et al.
Publicado: (2020)

Correction to: Cardiovascular risk factors and body composition in adults with achondroplasia
por: Fredwall, Svein O., et al.
Publicado: (2021)

Fat infiltration in the thigh muscles is associated with symptomatic spinal stenosis and reduced physical functioning in adults with achondroplasia
por: Fredwall, Svein O., et al.
Publicado: (2023)

Physiologically Realistic and Validated Mathematical Liver Model Revels Hepatobiliary Transfer Rates for Gd-EOB-DTPA Using Human DCE-MRI Data
por: Forsgren, Mikael Fredrik, et al.
Publicado: (2014)

Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis
por: Jongbloed, Sarah L, et al.
Publicado: (2006)

Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis
por: Ooms, Alexander, et al.
Publicado: (2023)

Body Composition Profiling in the UK Biobank Imaging Study
por: Linge, Jennifer, et al.
Publicado: (2018)

A pilot study investigating the use of 4D flow MRI for the assessment of splanchnic flow in patients suspected of mesenteric ischaemia
por: Hall Barrientos, Pauline, et al.
Publicado: (2021)

Poor prognostic factors in predicting abatacept response in a phase III randomized controlled trial in psoriatic arthritis
por: Mease, Philip J., et al.
Publicado: (2020)

Targeted systemic therapies for psoriatic arthritis: a systematic review and comparative synthesis of short-term articular, dermatological, enthesitis and dactylitis outcomes
por: McInnes, Iain B, et al.
Publicado: (2022)

Impaired dendritic cell proinflammatory cytokine production in psoriatic arthritis
por: Wenink, Mark H, et al.
Publicado: (2011)

Comparing hepatic 2D and 3D magnetic resonance elastography methods in a clinical setting – Initial experiences
por: Forsgren, Mikael F., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q5eje60euv0c9q2sac3r65ol27